Navigation Links
Biotech Cools Off in August But Capital Markets Remain Positive
Date:9/1/2009

SAN FRANCISCO, Sept. 1 /PRNewswire/ -- Just as biotech was "hot" in July it was a different story in August as the Burrill Biotech Select Index suffered from the summer "blahs" and posted a lackluster performance to close down 1.1 percent. The broader markets, on the other hand, continued their upward swing with the Dow closing the month up a healthy 3.5 percent and the Nasdaq closing up 1.5 percent.

Investors were, however, reminded on the last day of the trading month, that despite Federal Reserve Chairman Ben Bernanke's assessment that the economy is on the verge of recovery, there is still some way to go yet. The Dow and Nasdaq dropped 0.5 and 1 percent respectively because a sharp drop in Chinese equities added to concerns about the relative strength of the global economy's recovery.

"The final quarter of the year is traditionally one of biotech's best," said G. Steven Burrill, CEO, Burrill & Company, a San Francisco based global leader in life sciences with activities in Private Equity, Venture Capital, Merchant Banking and Media, "and we will likely see, despite the market uncertainties, the industry build on its momentum gained during the past several months.

"Although biotech's year-to-date performance lags the general markets there have been some encouraging signs that investors are coming back spurred in July by the market performances of companies such as Human Genome Sciences and Targacept and the marquee acquisition of Medarex by Bristol-Myers Squibb. In addition, we did see an IPO get out the door in August. Cumberland Pharmaceuticals raised $85 million by offering 5,000,000 shares at $17.00, below the expected range of $19.00 to $21.00. The specialty pharmaceuticals company has products on the market, including a new injectable treatment for pain and fever, which is one of the reasons why the deal got done," noted Burrill.

"The Cu
'/>"/>

SOURCE Burrill & Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Kangtai Cactus Biotech to Launch Patented Cactus-based Low Tar, Low or Zero Nicotine Cigarettes
2. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
3. Oncolytics Biotech(R) Inc. Announces Issuance of 32nd U.S. Patent
4. SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies
5. Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results
6. Malaysian Biotechnology Sector
7. PCI Biotech Commences Phase I/II Trials of Amphinex(R)
8. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
9. CBI Hosts 5th Annual Pharma/Biotech Enterprise Governance, Risk and Controls Congress
10. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
11. Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Two champions ... continued their sponsorship of an annual competition for middle ... and access to, innovative STEM study. The competition presents ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
(Date:1/15/2014)... 2013 was a banner year of continued innovation ... continued independent research led by the team at Wake ... million grant from the Susanne Marcus Collins Foundation, had ... reviewed journal, Amy Grant highlighted Brainwave Optimization® in First ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... February 28, Evotec AG (Frankfurt Stock Exchange: EVT) ... study for EVT 302 in smoking,cessation, a reversible ... This double-blind, three-way cross-over study is designed ... and withdrawal symptoms,after short-term deprivation of cigarettes in ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today ... Options in Healthcare Conference on Tuesday,March 4, 2008 at ... being,held at the W Hotel in New York., ... Anadys,Pharmaceuticals, Inc., will present an overview of Anadys and ...
... time, researchers at North Carolina State University have ... physically or chemically different so-called Janus particles ... alternating electrical field is applied to liquid surrounding ... published in the Feb. 8, 2008, edition of ...
Cached Biology Technology:Evotec Starts Phase II in Smoking Cessation with EVT 302 2Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference 2'2-faced' particles act like tiny submarines 2
(Date:7/9/2014)... derived from the oils produced by algae may offer ... this goal, optimization of cost effective strategies for large-scale ... needed. Sapphire Energy has developed an innovative solution to ... systems, described in Industrial Biotechnology , a peer-reviewed ... is available on the Industrial Biotechnology ...
(Date:7/9/2014)... about the prevalence of antibiotic-resistant illness, Case Western ... to disabling disease: blocking bacteria,s access to iron ... bacterial siderophore, a small molecule, captures iron from ... as well as how the body launches ... findings appear in a recent edition of ...
(Date:7/9/2014)... usually announce themselves with pain and fever but often can ... that are sneaky and hard to beat. Now, scientists have ... of tiny DNA pyramids. Published in the journal ACS ... can flag bacteria and kill more of them than medicine ... some infectious pathogens can lie in wait, undetectable in the ...
Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Bacteria hijack plentiful iron supply source to flourish 2
... genes significantly affect variation in voter turnout, shedding new ... in the political system. The research, conducted by ... UC San Diego) and psychologist Laura A. Baker (of ... of the American Political Science Review , a ...
... from research groups around Australia, the report includes chapters ... focus on steps that can be taken to adjust ... to the Farm Writers Association of NSW in Sydney ... Howden, said it was time for agriculture to start ...
... through a tropical or temperate forest immediately impresses us ... plant world, but our knowledge of how plants are ... Now, with data emerging from many genome sequencing projects, ... architecture at the molecular level. This knowledge has ...
Cached Biology News:Why do people vote? Genetic variation in political participation 2How to build a plant 2How to build a plant 3
... the needs of the biopharmaceutical ... supports fast cell growth rates ... maintaining high cell viability and ... the Baculovirus Expression Vector System ...
Mol wt: average mol wt12,360.96 Da by calculation...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
Biology Products: